WO1990000888A1 - Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide - Google Patents

Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide Download PDF

Info

Publication number
WO1990000888A1
WO1990000888A1 PCT/US1988/002526 US8802526W WO9000888A1 WO 1990000888 A1 WO1990000888 A1 WO 1990000888A1 US 8802526 W US8802526 W US 8802526W WO 9000888 A1 WO9000888 A1 WO 9000888A1
Authority
WO
WIPO (PCT)
Prior art keywords
implant
layer
sheet
tissue
sheets
Prior art date
Application number
PCT/US1988/002526
Other languages
English (en)
Inventor
Harold A. Markham
Original Assignee
The Cooper Companies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Cooper Companies, Inc. filed Critical The Cooper Companies, Inc.
Priority to PCT/US1988/002526 priority Critical patent/WO1990000888A1/fr
Priority to ES888802632A priority patent/ES2010327A6/es
Publication of WO1990000888A1 publication Critical patent/WO1990000888A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907—Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30909—Nets
    • A61F2002/30911—Nets having a honeycomb structure

Definitions

  • This invention relates to implants for implan ⁇ tation in the human body which resist the formation of firm spherical encapsulation.
  • Implants are widely used in the human body to substitute for missing tissue or structure, thereby emulating more natural, or creating more pleasing, external body contours.
  • An example is the mammary prosthesis, which is used for cosmetic augmentation, and for tissue replacement in reconstructive proce ⁇ dures.
  • Other shapes exist to augment or replace other tissues or types of tissues, for example testicular prostheses to simulate a missing testicle.
  • Other types of devices are implanted, often for a medical or a physiological objective, rather than for cosmetic advantage.
  • One such implant is the pacemaker, which is a device which is subcutaneously implanted at the ster- num, and which delivers electrical currents to a heart which does not reliably generate its own currents. Newer variants of such devices sense fibrillation in the heart, and deliver corrective currents.
  • Still other examples are porous bodies which contain pharma- ceuticals to be released gradually into the body.
  • mate ⁇ rial when in contact with tissue must be tissue- compatible to avoid rejection, must not be carcino- genic, and for mammary implantation, its body must have physical properties such as density, deformability in the sense of pliability, shape, memory, and the like, that enable it reasonably to simulate the tissue which otherwise would normally be there.
  • physical properties such as density, deformability in the sense of pliability, shape, memory, and the like, that enable it reasonably to simulate the tissue which otherwise would normally be there.
  • Still another problem can result from exces- sive penetration of surrounding tissues and fluids into the prosthesis. Then the prosthesis as a gross body takes on different properties to a greater depth than that of a mere encapsulation. Again, the undesirable result is a palpably distinguishable and often quite firm or even hard structure.
  • Soft tissue replacement or augmentation pros- theses are not the only types which are affected by this tissue reaction.
  • the perceived effect is one of a con ⁇ striction of the tissue around the body, which is very uncomfortable.
  • prosthesis design involves several sets of problems.
  • the easiest to attend to is the approxi ⁇ mation of gross properties, such as palpability, spe ⁇ cific gravity, total weight, suitable shapes, and the like, when these are appropriate. This is because these gross properties can readily be achieved by suit- able modification of readily available materials.
  • the problem becomes much more complicated, and unless the problem is fully solved, there is a high risk of formation of a too firm or even a hard encapsu ⁇ lation which ultimately may require surgical interven ⁇ tion.
  • prostheses from a plurality of materials - one for the inner mass of the prosthesis, and another for the external wall or sur- face.
  • the purpose in soft tissue replacement or aug ⁇ mentation is to provide the most biologically and structurally compatible properties for the external interface between the prosthesis and the contiguous tissue, thereby acting as a delivery system so that the implant's "filling" can achieve the gross tissue- emulating objectives.
  • the raw filling material could not have made a suitable interface.
  • prostheses involve the additional requisite that, even though the filling such as a gel or liquid is usually contained in an envelope of some kind, the contained material still must not be harmful to the patient in case the envelope is violated such as by being pierced, or if it somehow leaks, or is otherwise permeable.
  • Other types of pros- theses for example pacemakers, are their own "fill ⁇ ing," i.e., a rigid case. They are not expected to leak, but neither is it desirable for firm spherical encapsulation to grow around them. It is even possible for the body to expel any type of encapsulated prosthe- sis through the skin, much as a piece of shrapnel is expelled if a hard encapsulation is formed.
  • Implantable prostheses other than metallic prostheses
  • mammary prostheses have had an interesting and relatively brief career, in part because tissue-compatible materials such as medical grade silicone elastomer and medical grade polyurethane are themselves of relatively recent origin.
  • Earlier prostheses tended to utilize a total core or block of a sponge-like foam material, because of all of the then available useful materials, its physical properties were closest to those of tissue cells. Also, any desired shape could readily be carved from a block of such material.
  • An example of such a prosthesis is shown in Pangman, U.S. Patent No. 2,842,775.
  • the core of a prosthesis is, such as a silicone body silicone sac filled with fluid or gel gel body with a sealed surface, or a plastic or metal case, the core should be able to be made proof against leakage of fluid into it or out of it unless leakage out of it is desired, as will later be dis ⁇ closed.
  • this invention relates primarily to soft tissue prostheses, and the principal embodiments refer to that use, the principal thrust of this inven ⁇ tion is not to the core itself, but to its covering, which is the interface with tissues and fluids, and which is intended to resist the formation of firm spherical encapsulations, and thereby to make any kind of implant more acceptable to the human body, still attaining a good fixation.
  • the covering for the core can even be loose from it, such being provided as a sac or a sleeve, in which the core is placed, the sac carrying the interface material on its surface.
  • the tissue often tended either to migrate into it to fill the layer, or to create a heavy surrounding layer of firm fibrous tissue. Both of these results are highly undesirable, because in one case the gross properties of the foam are undesirable altered, and in the other, the foam becomes encapsulated by a structure which obscures the gross properties, or prevents them from being utilized, and adds a texture or rigidity of its own.
  • the inventor has, to his satisfaction, and to the satisfaction of extensive scientific and clinical trials, developed a prosthesis (implant) which has uniformly from component-to-component and uniformly over the entire critical surface of the prosthesis, been successfully functional.
  • the objec ⁇ tive has been to provide a prosthesis which can be surfaced with a layer of material that provides sub ⁇ stantial intercellular continuity without hard spherical encapsulation and contracture.
  • An example of the closest prior art, which reflects many of the above problems, and in which the instant inventor participated, is described in "Further Studies on the Natural-Y Breast Prosthesis," Vol. 49, No. 4, copyright 1972. In this article, there is described an earlier prosthesis with a silicone bag that is filled with some suitable substance.
  • This invention is used for implantation of a core, which core comprises a bulk in the sense of hav ⁇ ing a volume which occupies space and has an outer surface (sometimes called a boundary layer) which is unsuitable for an interface with surrounding tissues and fluids. In a pacemaker or other rigid articles, for example, this would be the smooth surface of its case.
  • the core provides various gross properties such as pli ⁇ ability, specific gravity, and the like which will be desired for the prosthesis as a unit.
  • a transition layer having as its outermost surface a tissue-receptive region.
  • the sac or sleeve will include a layer which is defined as the boundary layer that will abut and surround the remainder of the core.
  • the tissue-receptive region of the transition layer provides a volume of fine microfiber-like struc ⁇ tures as the outer surface of the prosthesis around which tissue will grow, and to which it will attach. Beneath a specific depth, the layer is closed to pene ⁇ tration by fluids and collagen and to tissue ingrowth by an adhesive that bonds the transition layer to the boundary layer.
  • tissue-receptive region permits controlled tissue ingrowth to the precise depth extent needed for accept ⁇ ance and fixation of the prosthesis, but inhibits pene ⁇ tration and ingrowth in excess of that amount, thereby avoiding the firm encapsulation so frequently experi ⁇ enced in the prior art.
  • the result appears to be the formation of a multitude of individual encapsu ⁇ lations around the various rough structures, but these encapsulations do not join up to form a grossly firm or hard encapsulation.
  • the bulk medium is made of a gel which is substantially self-shape retaining at body temperatures. While it is supple and palpable, it has sufficient memory to return to its normal shape. It does not slump appreciably at body temperatures.
  • the boundary layer is a coating of a resilient sealant which itself elastically and flexibly adapts to changes in the shape of gel core such as are caused by palpa ⁇ tion. No claim of originality is made to this form of core per se.
  • the boundary layer could be a pre ⁇ formed envelope of more substantial thickness in which the gel is poured and cured.
  • This envelope itself may provide some shape retention properties, and it might retain liquids instead of a gel. Again, no claim of originality is made to this form of core per se.
  • tissue-receptive layer is an open-cell icrofiber foam, laser-cut to a precise and uniform thickness so as to form those microfiber-like structures preferably without loose fragments, and so the depth of penetration can be pre ⁇ cisely determined and controlled.
  • the core may be left unsealed against the egress of certain molecular sizes so that medicines may exude from the implant.
  • Fig. 1 is a side view of a mammary prosthesis incorporating the presently preferred embodiment of the invention
  • Fig. 2 is a top view of Fig. 1;
  • Figs. 3 - 7 show successive steps in the manu ⁇ facture of the prosthesis of Fig. 1;
  • Fig. 8 is a bottom view of Fig. 1;
  • Fig. 9 is a schematic showing of one form of optional shape support;
  • Figs. 10 and 11 are respectively side fragmen ⁇ tary top views of another optional internal shape sup ⁇ port;
  • Fig. 12 is a plan view of pacemaker incorpo ⁇ rating the invention
  • Fig. 13 is a cross-section taken at line 13-13 in Fig. 12
  • Fig. 14 is a cross-section of another embodi ⁇ ment of the invention.
  • Fig. 15 is a cross-section of still another embodiment of the invention.
  • Fig. 1 shows the general contours of a mammary prosthesis 20 which incorporates the invention.
  • This prosthesis is used for augmentation.
  • Such prostheses may have numerous shapes and purposes. This invention is not limited to the shapes shown or to mammary appli ⁇ cations. It is of general applicability.
  • FIG. 9 A very common shape which is related to the external contour of the breast which can be for tissue replacement or augmentation is shown in Fig. 9.
  • Other shapes can be made for other types of replacements, for example, in the neck or shoulder.
  • the shape of the prosthesis will be made to conform to and fill the respective region of the body.
  • the illus- trated shape in Fig. 1 is a useful one for breast aug ⁇ mentation and is a useful example for teaching how to manufacture any suitably shaped prosthesis according to the invention.
  • Other types can be similarly manufac ⁇ tured and appropriately shaped for the intended use. With respect to the cross-section shown in
  • the pros ⁇ thesis 20 is shown having a core comprising a bulk medium 21 with an outer boundary layer 22.
  • Layer 22 is a sealant contiguous to and adherent to the outer surface of the gel itself.
  • Medium 21 and layer 22 comprise a "core.”
  • Layer 22 seals the bulk maxim from fluid migration into it, and is intended to make as good a seal to prevent outward bulk material migration as possible.
  • Layer 22 in the example is a formed-in- place layer, applied to a gelled core. Alternatively, it may instead be a pre-formed envelope of similar material, into which core material is placed. This core material may remain fluid, or may be cured to a self-shape retaining condition as preferred. This layer is considered to be a portion of the core.
  • An adhesive layer 23 is applied to the bound ⁇ ary layer, and a transition layer 24 is adhesively bonded to the sealant layer by layer 23.
  • the transi ⁇ tion layer is formed from two sheets 25 and 26, each laid upon a respective side of the core. The edges of the sheets are heat sealed together to form a continu ⁇ ous, thin and very flexible feathered edge 27, all as will be more fully described below.
  • a mold 30 is shown having a cavity 31 formed between two mold parts 32 and 33.
  • a suitable vent 34 or vents will be provided for supply and vent- ing in accordance with conventional molding practice.
  • the materials which form the gel will be poured through the vent or other supply passage and the gel will be cured while in the mold, the cavity having been formed to the ultimately desired shape.
  • the com- position of the gel and the chemical methods for form ⁇ ing it will be described later.
  • the gel After the gel has been fully cured in the mold (the mold usually being heated to assist in the gela ⁇ tion process) , the gel will itself constitute a self- shape retaining body — a bulk medium. It is, however, sticky and difficult to handle. Furthermore, despite all efforts to remove unreacted materials, there some ⁇ times will be some present. For these reason, it is good practice and efficacious to encapsulate the gel core in an outer boundary layer, preferably a thin, flexible and elastic sealant layer.
  • the outer boundary layer should be resilient and deformable so that its shape can readily change to conform to changes in the shape of the prosthesis caused by such actions as squeezing, and impermeate to the gel and its components unless for some reason per ⁇ meation is desired.
  • the boundary layer is applied, preferably while the gel core is still in its mold, by brush coat ⁇ ing or knife coating the gel core with one part of the mold removed, then curing it, then turning the core over into the other mold part and coating and curing the other surface after removing the other mold part.
  • This is a painstaking task, because the boundary layer when applied in this way is not intended to be more than approximately 0.002 inch thick, and complete coat ⁇ ing of the surface is desired without excessive build up of material anywhere.
  • the boundary layer When the boundary layer is cured, the core can be handled as a unit. It is only slightly tacky. The gel will not appreciably penetrate the boundary layer.
  • Transition layer 24 comprised of sheets 25 and 26, is laid upon the outer boundary for fixation and ingrowth of tissue. While other materials can be used instead, it has been found that very beneficial results are obtained when the transition layer is made from an open cell foam.
  • the foam is made from any material which is compatible with body tissues and fluids. At the present time polyurethane foam is the best substance. However, as they become available, foams of Teflon, polypropylene and dacron will also be suitable.
  • the foam is formed as a block, and sheets are cut from it to form a surface of microfiber structures, without friable particles. The cell size and population are such that a laser cut produces a surface with about seven linear cross-linked fibers of less than 0.01 mm thickness each per millimeter along the surface, free of friable pieces.
  • the foam is high density, so that the cells are quite small.
  • the sheet thickness is about 1.0 mm.
  • the uniformity of thickness is of nearly as great importance as the actual thickness. Sheets this thin of such material re readily penetrated by fluids.
  • the purpose of these sheets is not to resist penetration by a fluid, but at one side to provide an innermost sur ⁇ face to be bonded to the boundary layer, and an outer- most roughened surface with a large number of micro thin fiber-like strands around which tissue can grow. Furthermore, it is desired that the depth of this pene ⁇ tration by tissues and fluids be limited. In this invention these results are obtained by laser cutting of the sheets, which enables the thickness to be very closely controlled, and by penetration of the adhesive into the layer to a specific depth, so as to close the foam to further penetration by tissues and fluids.
  • the depth of penetration is best controlled by choosing the appropriate viscosity of the adhesive, and the amount of liquid adhesive applied. Too much adhe- sive will soak through, and too little will either not make the bond to the boundary surface, or will not pen ⁇ etrate far enough. Uniform and accurate application of the adhesive is an acquired skill, but it is one that can be learned.
  • the layer of liquid adhesive 23 is applied to the surface of the sealant layer, usually by a brush or by a knife or trowel. Blotting the surface to remove excess sealant is also a useful technique. Then one of the sheets is laid carefully over the surface of adhesive, without minimum stretching or bunching. The prosthesis is turned over and the other sheet is applied in the same way. The sheets are carefully smoothed out, care being taken not to thin them out too much by excessive (or any) stretching. The adhesive, being liquid until it cures, penetrates into the foam.
  • the viscosity and amount of the adhesive are carefully regulated such that it penetrates only as far as desired, so as to leave a correct volume of unoccluded microfiber struc ⁇ tures and open cells, while sealing the innermost cells and adhering the transition layer to the core.
  • the edges 35 of the sheets are brought together as shown in Figs. 6 and 7, and a heat sealing iron is brought together as shown in them immediately adjacent to the core. This melts the polyurethane which projects beyond the core of the prosthesis and fuses the layers together to form a flexible and thin feathered edge, which neatly finishes the edge of the prosthesis without creating a hard, palpable structure.
  • a hard edge structure has been a known disadvantage of some prior art prostheses. This edge can be used as additional attachment and orientation means.
  • Fig. 9 shows an optional construction of a prosthesis 40 in which three webs 41, 42, 43 are joined together at a trihedral edge 44, and are embedded in a gel structure 45 which can then receive boundary layer 22 as before to form a core.
  • Prosthesis 40 may be fin ⁇ ished with an adhesive layer and transition layer (not shown) as in Fig. 1. This is a prosthesis of the same type, but with internal reinforcement and a different shape.
  • a reinforcement plate 50 is shown with a base 51 which can fit inside the bulk medium near one of its sides, and a honeycomb structure 52 with open ended cavities 53 rising from it. Gel poured into these cavities and around the structure will have a basic structure less subject to slump and deformation.
  • Such internal reinforcements as shown in Figs. 9, 10, and 11 are optional and usually will not be required or used.
  • any type of core can be finished with the transition layer as described.
  • a silicone sac or envelope adapted to hold a liquid can have the same adhesive layer and transition layer to form attachment means for the prosthesis, thus giving it additional and beneficial properties.
  • the envelope would be pre-formed and then filled with fluid which may either remain fluid, or be cured to be self-shape retaining.
  • a pouch or sac 100 shown which has a pouch- like fluid-impermeable skin or envelope 101.
  • a transi ⁇ tion layer 102 identical to the previously described transition layer is attached to it including the adhe ⁇ sive material 103 partially migrated into it over sub ⁇ stantially its entire surface.
  • Any desired device, such as a pacemaker, can be inserted into the pouch through opening 105, and the opening will then be closed. All advantages of this invention are then attained.
  • the bulk medium is a gel preferably made of medical grade dimethyl polysiloxane of the type obtainable from Dow
  • Corning Corporation It is a two component system, and the properties of the gel will be determined by the proportion of the cross-linker in the two component mixture.
  • This material is usually mixed in a batch to make a number of gel structures in a plurality of molds at the same time. The proportions are selected such that a two inch diameter, one half inch thick, disk of the cured material when bent ninety degrees will be slightly wrinkled all over its inside surface.
  • Such test disks can readily be made and cured on an accel ⁇ erated basis to make this test in order to adjust the relative proportions of the two components.
  • curing will usually take about six- teen hours at approximately 150 degrees F.
  • the boundary layer 22 is also made of medical grade dimethyl polysiloxane from Dow Corning Corpora ⁇ tion and is also heat cured. Its thickness is prefera ⁇ bly about 0.002 inch when applied wet and cured. A preformed envelope will usually have a thickness between about 0.008 and 0.015 inches.
  • the adhesive layer 23 is a room-temperature vulcanizing medical grade dimethyl polysiloxane obtainable from Dow Corning Corporation and also is applied as a very thin layer so as to penetrate only a small distance into the transi ⁇ tion tissue layer 24, usually to about one half of the thickness. Certainly too little is provided for the adhesive to soak all the way through the foam. The outer foam surface must be adhesive-free to such an extent that an adequate depth of exposed fibers and unsealed cells exists for retention and penetration and continuity of cells and fluids. Uniformity of penetra ⁇ tion over the entire surface is an objective.
  • the transition layer is preferably approxi ⁇ mately one millimeter thick and is made of high density polyurethane, open-cell material with cell size and population as specified elsewhere to give correct prop ⁇ erties. Because the outermost surface of the transi ⁇ tion layer is made by a straight cut across a block, the density of fibers is a function of the foam cell population and size. The fibers are, of course, the remnants of the foam cell walls, and are of random shape. This provides a desirable surface "roughness" in the sense of inconsistencies, but within acceptable size range. Just beneath this group of fibers there is a region of complete open cells. These permit cell and fluid penetration.
  • the depth of this region is limited by the incursion of the adhesive, which fills the cells on the bottom side to the appropriate depth.
  • the transition layer could be pro ⁇ vided as a pair of joined-together layers, for example, with an outer surface adapted for tissue ingrowth and fluid penetration, and another foam layer attached to it and to the boundary layer for structural reinforce- ment of the outer layer and attachment to the core, but this would be a difficult structure to make, especially in contrast to the easily manufactured layer described above.
  • the inner layer would then be closed foam, or even an impermeable material.
  • a core having a gel center is merely one embodiment.
  • the surface treatment of the prosthesis can be applied to any type of core, and its utility is not limited to usage with a gel-filled or shape-retaining core.
  • the utility and application of all types of cores can be remarkably improved - even the liquid-filled envelope type.
  • the total thickness of the outer layer is not of importance except to the extent that it might adversely affect the gross properties of the prosthe ⁇ sis. What is important is the quality and depth of the surface which permits penetration and ingrowth, i.e., the region of open cells and fibers. This depth should be just sufficient to permit fixation, and should be insufficient to provide such depth for collagen and tissue incursion that a firm capsule can be contributed to.
  • the prosthesis has a relatively rounded side, and a frusto- conical side. In plan it is circular. This is a use ⁇ ful shape for augmentation.
  • the frusto-conical side faces the rib cage. When the breast is brought down against it, the frusto-conical shape gives some lateral restraint, so the prosthesis does not tend to flatten and roll as a pillow. This is an example of the wide range of shapes and functions which are attainable with this invention.
  • Figs. 12 and 13 show a core 110 comprising an article 111 to be implanted, such as a pacemaker. Instead of being placed in a pouch as in Fig. 14, its own surface 112 is used to support the transition layer.
  • the transition .layer 113 is adhered to the article by adhesive 114 which penetrates part way into the transition layer. It is all ways identical to the transition layers described above. A metal case requires no sealing. While the cores described this far have been described as sealed, it will be recognized by persons skilled in the art that silicone articles will over the years exude some of their material.
  • a sufficient seal ⁇ ant thickness is provided to at least repress this effect, and this is defined as "sealed.”
  • con ⁇ cern is the tendency of some lower molecular weight materials to migrate into the core. Again the integ ⁇ rity and thickness of the sealant are intended to be such as to repress this tendency.
  • the use of a pre-formed envelope will often be preferred to the use of a sealant which is applied to the bulk material. This is because the envelope can be tested for flaws and leaks, while the applied sealant layer cannot be tested.
  • Fig. 15 shows an extension of the inventive concept.
  • a rod 120 of a material that is infused with a medication is intended to be implanted in the body, and remain there for a considerable period of time, there are presently proposes such rods with a contra ⁇ ceptive pharmaceutical which are expected to remain implanted for up to five years.
  • a steady migration of the pharmaceutical is intended, and a hard encapsulation could frustrate this objective.
  • the invention provides for fixation and closure of the transition layer to incursion of tissue and fluids below a given depth, ⁇ ut the sealant is selected so as to accommodate migration of the phar ⁇ maceutical through it.
  • rod 120 is placed within a sleeve 121.
  • the sleeve is crimped or otherwise sealed at both ends. It has a boundary layer 122 and a transition layer 123.
  • the transition layer is adhered to the boundary layer by adhesive 124 as described in the other embodiments.
  • this invention provides a tissue- compatible interface for many types of implants and prostheses. It can be applied directly to the core article itself, as in Figs. 1-13, or can be applied to a cover as in Fig. 14.
  • the "cover” can be considered as a core or as part of a core. Test implants in animals have shown that pros- theses with a transition surface as described are well- received. There is no tendency to harden or to become firmly encapsulated or distorted, and the properties are remarkable consistent all over the surface.

Abstract

Est décrite une couche de transition (24) pour un implant destiné à être placé dans le corps humain. Cet implant comporte un noyau (21) entouré de la surface de transition. La couche de transition (24) est une mousse à alvéoles ouvertes munie de surfaces découpées. Une colle (23) adhère à une surface du noyau (21) et pénètre dans la couche de transition (24) sur une distance limitée de manière à laisser, sur la surface entière, des microstructures de fragments cellulaires permettant la fixation tissulaire sans formation d'un encapsulement raide.
PCT/US1988/002526 1988-07-28 1988-07-28 Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide WO1990000888A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US1988/002526 WO1990000888A1 (fr) 1988-07-28 1988-07-28 Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide
ES888802632A ES2010327A6 (es) 1988-07-28 1988-08-25 Implantaciones protesicas con recubrimiento resistente a la formacion de encapsulacion esferica consistente.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/002526 WO1990000888A1 (fr) 1988-07-28 1988-07-28 Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide

Publications (1)

Publication Number Publication Date
WO1990000888A1 true WO1990000888A1 (fr) 1990-02-08

Family

ID=22208808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/002526 WO1990000888A1 (fr) 1988-07-28 1988-07-28 Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide

Country Status (2)

Country Link
ES (1) ES2010327A6 (fr)
WO (1) WO1990000888A1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007525A1 (fr) * 1990-10-31 1992-05-14 Baxter International Inc. Matiere d'implant pour vascularisation proche
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
WO1996010966A1 (fr) * 1994-10-07 1996-04-18 Baxter International Inc. Structures de membranes polymeres poreuses micro-fabriquees
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
EP0786969A1 (fr) * 1994-10-17 1997-08-06 William J. Seare, Jr. Procedes et appareil permettant de creer une poche corporelle
US6060639A (en) * 1994-03-04 2000-05-09 Mentor Corporation Testicular prosthesis and method of manufacturing and filling
US6773458B1 (en) 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
US7476249B2 (en) 2004-08-06 2009-01-13 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US8007531B2 (en) 2004-08-06 2011-08-30 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
EP2581193A1 (fr) * 2011-10-14 2013-04-17 Polytech Health&Aesthetics GmbH Procédé pour la fabrication d'implants ou de produits intermédiaires de tels implants et implants et produits intermédiaires ainsi obtenus
WO2015020866A3 (fr) * 2013-08-07 2015-10-29 Techno Investments Llc Implant mammaire hybride et expanseur tissulaire, procédé pour les fabriquer et les utiliser
CN106551732A (zh) * 2011-08-11 2017-04-05 波里泰克健康和美学股份有限公司 可植入式医学假体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559214A (en) * 1968-10-17 1971-02-02 William J Pangman Compound prosthesis
US3683424A (en) * 1970-01-30 1972-08-15 William J Pangman Surgically implantable compound breast prosthesis
US4307472A (en) * 1978-06-12 1981-12-29 Glasrock Products, Inc. Prosthetic device with rigid implantable member having bonded porous coating

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559214A (en) * 1968-10-17 1971-02-02 William J Pangman Compound prosthesis
US3683424A (en) * 1970-01-30 1972-08-15 William J Pangman Surgically implantable compound breast prosthesis
US4307472A (en) * 1978-06-12 1981-12-29 Glasrock Products, Inc. Prosthetic device with rigid implantable member having bonded porous coating

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741330A (en) * 1990-10-31 1998-04-21 Baxter International, Inc. Close vascularization implant material
US5782912A (en) * 1990-10-31 1998-07-21 Baxter International, Inc. Close vascularization implant material
US5882354A (en) * 1990-10-31 1999-03-16 Baxter International Inc. Close vascularization implant material
US5800529A (en) * 1990-10-31 1998-09-01 Baxter International, Inc. Close vascularization implant material
WO1992007525A1 (fr) * 1990-10-31 1992-05-14 Baxter International Inc. Matiere d'implant pour vascularisation proche
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5593440A (en) * 1990-10-31 1997-01-14 Baxter International Inc. Tissue implant systems and methods for sustaining viable high cell densities within a host
US5733336A (en) * 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US6773458B1 (en) 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US6060639A (en) * 1994-03-04 2000-05-09 Mentor Corporation Testicular prosthesis and method of manufacturing and filling
WO1996010966A1 (fr) * 1994-10-07 1996-04-18 Baxter International Inc. Structures de membranes polymeres poreuses micro-fabriquees
US5807406A (en) * 1994-10-07 1998-09-15 Baxter International Inc. Porous microfabricated polymer membrane structures
EP0786969A1 (fr) * 1994-10-17 1997-08-06 William J. Seare, Jr. Procedes et appareil permettant de creer une poche corporelle
EP0786969A4 (fr) * 1994-10-17 1998-07-29 William J Seare Jr Procedes et appareil permettant de creer une poche corporelle
US7476249B2 (en) 2004-08-06 2009-01-13 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US8007531B2 (en) 2004-08-06 2011-08-30 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
CN106551732A (zh) * 2011-08-11 2017-04-05 波里泰克健康和美学股份有限公司 可植入式医学假体
EP2581193A1 (fr) * 2011-10-14 2013-04-17 Polytech Health&Aesthetics GmbH Procédé pour la fabrication d'implants ou de produits intermédiaires de tels implants et implants et produits intermédiaires ainsi obtenus
CN103040543A (zh) * 2011-10-14 2013-04-17 波里泰克健康和美学股份有限公司 制造植入物或该植入物的中间产品的方法以及通过该方法获得的植入物和中间产品
AU2012238270B2 (en) * 2011-10-14 2015-02-05 Polytech Health & Aesthetics Gmbh Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
EP3002101A1 (fr) * 2011-10-14 2016-04-06 Polytech Health&Aesthetics GmbH Procédé pour la fabrication d'implants ou de produits intermédiaires de tels implants et implants et produits intermédiaires ainsi obtenus
CN103040543B (zh) * 2011-10-14 2017-11-21 波里泰克健康和美学股份有限公司 制造植入物或该植入物的中间产品的方法以及通过该方法获得的植入物和中间产品
KR101812963B1 (ko) 2011-10-14 2017-12-28 폴리테크 헬스 운트 에스테틱스 게엠베하 보형물 또는 그러한 보형물의 중간생성물의 제조 방법 및 상기 방법에 의해 얻어진 보형물 또는 그러한 보형물의 중간생성물
US10307945B2 (en) 2011-10-14 2019-06-04 Polytech Health & Aesthetics Gmbh Process or the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
WO2015020866A3 (fr) * 2013-08-07 2015-10-29 Techno Investments Llc Implant mammaire hybride et expanseur tissulaire, procédé pour les fabriquer et les utiliser

Also Published As

Publication number Publication date
ES2010327A6 (es) 1989-11-01

Similar Documents

Publication Publication Date Title
US5141581A (en) Implants with a cover which resists formation of firm spherical encapsulation
US3681787A (en) Implantable breast prosthesis filled with gels of different densities
AU683733B2 (en) Implantable prosthesis with open cell textured surface and method for forming same
EP0174141B1 (fr) Dispositif de prothèse implantable
US5658330A (en) Molded silicone foam implant and method for making
US4740208A (en) Cast gel implantable prosthesis
US4820303A (en) Implantable prosthetic devices
WO1990000888A1 (fr) Implants pourvus d'un revetement resistant a la formation d'un encapsulement spherique raide
EP2250974B1 (fr) Dispositifs dotés d'une surface texturée
US4963150A (en) Implantable prosthetic devices
US4470160A (en) Cast gel implantable prosthesis
US4840628A (en) Non-enveloped gel prosthesis
US4859712A (en) Silicone foam and method for making it
US4960425A (en) Textured surface frosthesis implants
US4205401A (en) Mammary prosthesis which resists capsular contracture
US5022942A (en) Method of making textured surface prosthesis implants
US5425762A (en) Prosthetic implants and process for obtaining the same
US3293663A (en) Surgically implantable human breast prosthesis
US5370688A (en) Encapsulated gel breast prosthesis and method of making
KR101235284B1 (ko) 응력집중을 최소화한 실리콘 인공유방 보형물 및 그 제조방법
US5527359A (en) Method of making positive and negative models for artificial breasts
EP0293256B1 (fr) Méthode pour la fabrication d'un Implant prothétique comprenant une surface texturée
WO1999017816A1 (fr) Implant comblant un espace recouvert de ptfe expanse
CA1166810A (fr) Prothese mammaire et methode de fabrication
CS202793B1 (cs) Mammární implantát

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU DK JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT NL SE